Use of Smartphone Health Applications Among Patients Aged 18 to 69 Years Recruited in Primary Care in Grenoble Area (Smartcheck)

May 6, 2018 updated by: Roussel Jérémy, University Grenoble Alps

This study evaluates the frequency of use of smartphone health applications among people consulting in primary care in the Grenoble region, France.

This is a descriptive study using a questionnaire completed by the patient and distributed by general practitioners. The study also collects the type of used application as well as the rhythm of usage, and compares the use of mobile health applications according to the sociodemographic, geographical and medical characteristics of the studied population.

Study Overview

Status

Completed

Conditions

Detailed Description

Smartphones are more and more present and change many aspects of people's life, especially in the field of health. The appearance of numerous mobile health applications over the past years explains this strong attractiveness.

According to some studies, these could lead to savings in health care systems by promoting a preventive approach and refocusing cares on the patient who would be more independent. However, not much data on the use of smartphone health applications by patients are reported in the scientific literature.

The main objective of this study is to evaluate the frequency of use of smartphone mobile health applications among primary care patients aged 18 to 69 in the Grenoble region, France.

The secondary objectives are the collection of the kind of application used, the rhythm of usage of these health applications and the comparison of the frequency of use with the sociodemographic, geographical and medical characteristics of the studied population.

To this end, the investigators use a questionnaire distributed by voluntary general practitioners and filled by patients. The number of subjects to be included is 385 and the number of distributed questionnaires is 1500.

Study Type

Observational

Enrollment (Actual)

597

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Chabons, France, 38690
        • Dr Ronflet
      • Grenoble, France, 38000
        • Centre de santé de l'abbaye
      • Grenoble, France, 38000
        • Dr CROS
      • Grenoble, France, 38000
        • Dr Grasset
      • La Côte-Saint-André, France, 38260
        • Dr Riehl
      • Meylan, France, 38240
        • Dr Fuentes
      • Moirans, France, 38430
        • Maison médicale Moirans
      • Montmelian, France, 73800
        • Dr PARADIS
      • Saint-Martin-d'Hères, France, 38400
        • Dr Chatellard
      • Saint-Martin-d'Hères, France, 38400
        • Dr Moulis
      • Saint-Martin-d'Hères, France, 38400
        • Maison médicale Saint Martin d'Hères
      • Tullins, France, 38210
        • Maison Médicale de Tullins
      • Villard de Lans, France, 38250
        • Dr Bichon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Population recruited in 12 general practictioners and 1 primary care center in Grenoble area in France.

Description

Inclusion Criteria:

  • Patients aged among 18 to 69 years old who consults a general practitioner regardless of the reason for consultation

Exclusion Criteria:

  • patients aged 17 and less and patients aged 70 years and over.
  • Patients not owning a mobile phone and / or smartphone for own
  • Patients deprived of their liberty by judicial or administrative decision or subject to a legal protection measure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of at least one mobile health application on a smartphone
Time Frame: month 1
Use of at least one mobile health application on a smartphone since the first use of a smartphone.
month 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socio-demographic characteristics
Time Frame: month 1
Age (years) Sex (F/M) socio-professional group
month 1
Geographical characteristics
Time Frame: month 1
Postcode
month 1
Names of applications used by the patient
Time Frame: month 1
The patient name the applications which he used. In order to help him/her , there are some examples of kind of applications.
month 1
Origin of the awareness of the existence of the mobile health application used.
Time Frame: month 1
How the patient became aware of the existence of used application: general practitioners, other doctors, other health professionals, media, social circle
month 1
Number of drugs on the prescription
Time Frame: month 1
number of drugs on the prescription.
month 1
Illness requiring treatment for more than a year
Time Frame: month 1
Diabetes, malignant tumor, psychiatric condition, cardiac diseases, rheumatological diseases, pulmonary diseases, chronic renal failure, other
month 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Grenoble Alps

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2017

Primary Completion (Actual)

January 7, 2018

Study Completion (Actual)

January 14, 2018

Study Registration Dates

First Submitted

November 8, 2017

First Submitted That Met QC Criteria

November 21, 2017

First Posted (Actual)

November 22, 2017

Study Record Updates

Last Update Posted (Actual)

May 8, 2018

Last Update Submitted That Met QC Criteria

May 6, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2017-A01647-46

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobile Applications

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe